AUSSCHEIDUNG HÄMHALTIGER POLYPEPTIDE

Patent europeic · EP3722431 · En vigur

Inscripziun en il register

Numer da publicaziun
EP3722431
Numer da la dumonda
EP20157598
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
En vigur
Scrittira da patent
Concedì
Annunzià
11-09-2014
Publitgà
14-10-2020
Concedì
10-06-2026
La protecziun finescha il pli tard
10-09-2034
Proxima taxa annuala scadenta
30-09-2026
Classas IPC
C12N 15/82 (2006.01)
C07K 14/805 (2006.01)
Prioritad
US 201361876676 P 11.09.2013
US 201361908689 P 25.11.2013
Derivà da
EP14844701
Lingua da l’annunzia
englais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 20-10-2026

    Adressa dal represchentant midada

    Representative
    Dr. Lusuardi AG, Kreuzbühlstrasse 8, 8008 Zürich → Dr. Lusuardi AG, Stockerstrasse 8, 8002 Zürich

    Published in Swissreg on 20.10.2026

  2. 10-06-2026

    Concedì

    Specification status
    Non-published patent application → Granted patent
    Status of protective title
    Initiated → Active

    Published in Swissreg on 10.06.2026

  3. 10-06-2026

    Represchentant inscrit

    Representative
    Dr. Lusuardi AG, Kreuzbühlstrasse 8, 8008 Zürich

    Published in Swissreg on 10.06.2026

Partidas

Inventur

FRASER, Rachel

San Francisco, CA California 94110, US

DAVIS, Simon Christopher

San Francisco, CA California 94110, US

BROWN, Patrick O'Reilly

Stanford, CA California 94305, US

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.